Skip to main content

Find Clinical Trials

Home
Conditions
Hepatocellular Carcinoma (HCC)

Clinical trial condition

Hepatocellular Carcinoma (HCC)

Explore clinical trials studying Hepatocellular Carcinoma (HCC). Study availability and eligibility vary by location and protocol.

243 public trials 102 recruiting studies

Refine in advanced search Browse all conditions

Hepatocellular Carcinoma (HCC) trial results

Not yet recruiting

Effect of Biejia-Ruangan Compound on Survival Rate and Recurrence Rate of Hepatocellular Carcinoma After Radical Treatment

NCT06923176

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Characteristic and Survival Outcomes in Hepatocellular Carcinoma Patients: on Top of Viral Hepatitis Versus Combined Viral and Metabolic-Associated Steatotic Liver Disease

NCT06871930

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Study to Compare the Efficacy, Safety, Immunogenicity, and Pharmacokinetic Profile of HLX13 with YERVOY As a First-Line Treatment for Patients with Unresectable Hepatocellular Carcinoma

NCT06841185

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

Ga-68 Dolacga PET Scan in HCC Under RFA

NCT06792097

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations: Not specified

View Trial Details

Not yet recruiting

The Use of AKR1B10 for Monitoring Postoperative Recurrence of Hepatocellular Carcinoma

NCT06750159

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Not specified

View Trial Details

Not yet recruiting

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

NCT06724263

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +46 more
Locations: Shanghai East Hospital Shanghai, Shanghai Municipality, China

View Trial Details

Not yet recruiting

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

NCT06685354

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Not yet recruiting

CAR-T Cell Therapy Targeting GPC3 in Patients with Advanced GPC3-Positive Hepatocellular Carcinoma

NCT06641453

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Biotherapeutic Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China

View Trial Details

Not yet recruiting

Therapeutic Effects of Immuno-targeted Therapy Combined With or Without RT for HCC

NCT06639971

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Enrolling by invitation

Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study

NCT07620574

Conditions: Adenocarcinoma, Cancer, Carcinoma, +39 more
Locations: New York Cancer and Blood Specialists Bay Shore, New York, United States

Greater Dayton Cancer Center Kettering, Ohio, United States

View Trial Details